Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for Glucocorticoid-induced Osteoporosis in Children
NCT02418273Phase 2Withdrawn
- Sponsor
- Indiana University
- Start
- Aug 2019
- Primary completion
- Jun 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in glucocorticoid-induced osteoporosis (GIOP), sponsored by Indiana University. Planned start Aug 2019; status: withdrawn.
02
Drugs
denosumab
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on NCT02418273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02418273.